Evidence map›Paper›PMID 39158355›Full record

ArticleCancer medicine2024

Comprehensive analysis of diagnosis and treatment in 99 cases of abdominal Schwannoma.

Shaoqing Fan, Haiqian Wang, Xuemei Sun, Chunyue Gai, Ce Liang, Guiying Wang, Wenbo Niu

Erratum issuedAbstract read
In one paragraph

Article in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cecal schwannoma: A case report and literature review.The Journal of international medical research · 2025
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Shaoqing FanDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.ORCID 0009-0007-5105-4550
Haiqian WangDepartment of Nursing, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Xuemei SunDepartment of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Chunyue GaiDepartment of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Ce LiangDepartment of Pharmacology, The Hebei Medical University, Shijiazhuang, Hebei, China.
Guiying WangDepartment of General Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Wenbo NiuDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.ORCID 0000-0003-2104-6975

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSchwannoma is a rare mesenchymal tumor. In this study, we analyzed clinicopathologically 99 schwannomas.This retrospective study delves into the clinical, pathological, and immunohistochemical dimensions of abdominal schwannomas.

resultsA cohort of 99 cases, comprising 4 malignant and 95 benign schwannomas, was meticulously examined. Clinical analysis revealed a notable gender distribution (1:1.7, male to female) and an average age of 58.5 years. The majority of cases were asymptomatic. A cohort of 99 cases, comprising 4 malignant and 95 benign schwannomas, was meticulously examined. Clinical analysis revealed a notable gender distribution (1:1.7, male to female) and an average age of 58.5 years. The majority of cases were asymptomatic. Tumor sizes ranged from 0.5 to 30 cm, with distinct locations in the stomach for most benign cases and the abdomen/small intestine for malignancies. Initial misdiagnoses were frequent. Pathological evaluations revealed distinct features, including Antoni A and B patterns, spindle cells, and lymphatic sheath structures in benign schwannomas. Malignant cases exhibited atypical cells, ulcers, and invasive growth. Immunohistochemical markers, such as S100, SOX10, and vimentin, consistently demonstrated positivity by contributing to accurate diagnoses. Treatment outcomes indicated a poor prognosis in malignant cases, with overall survival ranging from 10 to 41 months. Conversely, benign cases displayed no recurrence or metastasis during follow-up, despite atypical behaviors.

conclusionThis study underscores the rarity of abdominal schwannomas and underscores the need for a comprehensive diagnostic morphology and immunohistochemistry. SOX10 emerges as a crucial and specific marker for accurate diagnosis. Further research is imperative to refine diagnostic protocols and enhance our understanding of the clinical behavior of abdominal schwannomas.

Indexed as

Abdominal NeoplasmsNeurilemmomaAdultAgedAged, 80 and overBiomarkers, TumorFemaleHumansImmunohistochemistryMaleMiddle AgedPrognosisRetrospective StudiesYoung AdultBiomarkers, Tumorabdominal schwannomagastrointestinal neuroectodermal tumorGNETS100SOX10

Identifiers

PMID39158355
PMCPMC11331592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.